Skip to main content
OK BIOTECH logo

OK BIOTECH — Investor Relations & Filings

Ticker · 4155 ISIN · TW0004155007 TW Manufacturing
Open in API
Filings indexed 1,726 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4155

About OK BIOTECH

http://www.okbiotech.com

OK Biotech Co., Ltd. is a medical device company specializing in the research, development, manufacturing, and global distribution of diagnostic and home healthcare solutions. Established in 2004, the company focuses on blood glucose monitoring systems, including high-precision meters and test strips, alongside over-the-counter (OTC) hearing aids and multiple frequency therapy devices. OK Biotech provides comprehensive services ranging from product design to complete factory setup solutions, supporting partners from initial planning through to mass production. By leveraging advanced R&D and production technologies, the company delivers reliable OEM and ODM solutions designed for both personal wellness and professional clinical applications. Its commitment to technical innovation ensures the delivery of high-quality medical instruments and tailored healthcare support to a global market.

Recent filings

Filing Released Lang Actions
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 86% confidence The document is a substantive table of financial data for the first quarter (115年1季) showing equity-method investments, ending balances, and recognized gains or losses. It is part of a quarterly report with actual financial statements content, not merely a notice or announcement. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季財務報告書 — 202601_4155_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a consolidated financial report and accountant’s review (PwC review report) covering the first quarter (Q1) of fiscal years 115 and 114, including balance sheets, income statements, cash flows, and notes prepared under IFRS 34 (interim reporting). It contains substantive financial statements for a shorter period than a full year. Therefore, it matches the definition of an Interim / Quarterly Report. Q1 2026
2026-05-14 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 93% confidence The document is a consolidated statement of changes in equity for the first quarter (民國115年第1季) presenting detailed financial line items (opening balance, dividends, net income, other comprehensive income, stock-based payments, ending balance) and a comparative prior period. This is substantive financial data for a quarterly period, indicating it is part of an Interim/Quarterly Report rather than an announcement or summary. Thus, it should be classified as IR. Q1 2026
2026-05-14 Chinese
115年第1季現金流量表
Interim / Quarterly Report Classification · 92% confidence The document is a standalone merged cash flow statement for the first quarter of the fiscal year (民國115年第1季) with detailed line‐item financial data (operating, investing, and financing cash flows). It contains substantive financial figures for a quarter, indicating it is part of an Interim/Quarterly Report rather than just an announcement. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季綜合損益表
Regulatory Filings Classification · 10% confidence The document is an error/security notice page indicating the page cannot be accessed. It contains no corporate filing content, no financial data, no meeting materials or announcements. It does not fit any specific category, so it defaults to a general regulatory filing placeholder.
2026-05-14 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document is a consolidated balance sheet presenting detailed financial data (assets, liabilities, equity) for the first quarter of the fiscal year, including comparisons to prior periods. It contains substantive financial statements for a period shorter than a full year (Q1), indicating an interim/quarterly report rather than an announcement or mere regulatory notice. Q1 2026
2026-05-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.